These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 29717819)

  • 1. Recent Advances in the Development of Antimicrobial Nanoparticles for Combating Resistant Pathogens.
    Lakshminarayanan R; Ye E; Young DJ; Li Z; Loh XJ
    Adv Healthc Mater; 2018 Jul; 7(13):e1701400. PubMed ID: 29717819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-Based Nanostructures for the Delivery of Natural Antimicrobials.
    Pinilla CMB; Lopes NA; Brandelli A
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34208209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
    Grumezescu AM; Chifiriuc CM
    Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Antimicrobial Applications of Chitosan Nanoparticles (ChNP).
    Rozman NAS; Tong WY; Leong CR; Tan WN; Hasanolbasori MA; Abdullah SZ
    J Microbiol Biotechnol; 2019 Jul; 29(7):1009-1013. PubMed ID: 31288302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid lipid nanoparticles carrying Eugenia caryophyllata essential oil: the novel nanoparticulate systems with broad-spectrum antimicrobial activity.
    Fazly Bazzaz BS; Khameneh B; Namazi N; Iranshahi M; Davoodi D; Golmohammadzadeh S
    Lett Appl Microbiol; 2018 Jun; 66(6):506-513. PubMed ID: 29569372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology-based drug delivery systems for control of microbial biofilms: a review.
    Dos Santos Ramos MA; Da Silva PB; Spósito L; De Toledo LG; Bonifácio BV; Rodero CF; Dos Santos KC; Chorilli M; Bauab TM
    Int J Nanomedicine; 2018; 13():1179-1213. PubMed ID: 29520143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano-fats for bugs: the benefits of lipid nanoparticles for antimicrobial therapy.
    Thorn CR; Thomas N; Boyd BJ; Prestidge CA
    Drug Deliv Transl Res; 2021 Aug; 11(4):1598-1624. PubMed ID: 33675007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial hydrogels: a new weapon in the arsenal against multidrug-resistant infections.
    Ng VW; Chan JM; Sardon H; Ono RJ; García JM; Yang YY; Hedrick JL
    Adv Drug Deliv Rev; 2014 Nov; 78():46-62. PubMed ID: 25450263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles: Alternatives Against Drug-Resistant Pathogenic Microbes.
    Rudramurthy GR; Swamy MK; Sinniah UR; Ghasemzadeh A
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27355939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Polymeric Nanoparticle-Encapsulated Drugs against Intracellular Infections.
    Sánchez A; Mejía SP; Orozco J
    Molecules; 2020 Aug; 25(16):. PubMed ID: 32824757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of nanoparticles for antimicrobial drug delivery.
    Zhang L; Pornpattananangku D; Hu CM; Huang CM
    Curr Med Chem; 2010; 17(6):585-94. PubMed ID: 20015030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
    Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
    Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity of polymyxin-loaded solid lipid nanoparticles (PLX-SLN): Characterization of physicochemical properties and in vitro efficacy.
    Severino P; Silveira EF; Loureiro K; Chaud MV; Antonini D; Lancellotti M; Sarmento VH; da Silva CF; Santana MHA; Souto EB
    Eur J Pharm Sci; 2017 Aug; 106():177-184. PubMed ID: 28576561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Polymer-Based Assemblies: A Review.
    Carmona-Ribeiro AM; Araújo PM
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34063877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic Insights into the Antimicrobial Actions of Metallic Nanoparticles and Their Implications for Multidrug Resistance.
    Shaikh S; Nazam N; Rizvi SMD; Ahmad K; Baig MH; Lee EJ; Choi I
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31109079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications.
    Rajpoot K
    Curr Cancer Drug Targets; 2020; 20(4):271-287. PubMed ID: 31951180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sol-gel encapsulation of binary Zn(II) compounds in silica nanoparticles. Structure-activity correlations in hybrid materials targeting Zn(II) antibacterial use.
    Halevas E; Nday CM; Kaprara E; Psycharis V; Raptopoulou CP; Jackson GE; Litsardakis G; Salifoglou A
    J Inorg Biochem; 2015 Oct; 151():150-63. PubMed ID: 26198972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Progress in Polymer Research to Tackle Infections and Antimicrobial Resistance.
    Konai MM; Bhattacharjee B; Ghosh S; Haldar J
    Biomacromolecules; 2018 Jun; 19(6):1888-1917. PubMed ID: 29718664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles for Antimicrobial Agents Delivery-An Up-to-Date Review.
    Mercan DA; Niculescu AG; Grumezescu AM
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives.
    Mukherjee A; Waters AK; Kalyan P; Achrol AS; Kesari S; Yenugonda VM
    Int J Nanomedicine; 2019; 14():1937-1952. PubMed ID: 30936695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.